Is AHCO stock a Buy, Sell, or Hold?

Based on our analysis, AHCO is currently a HOLD with low confidence. 📊 HOLD: AHCO shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.

What is the fair value of AHCO stock?

Our analysis estimates the fair value range for AHCO to be between $11.65 and $12.99. The current price is $10.74.

What is the analyst price target for AHCO?

The average Wall Street analyst price target for AHCO is $14.00. This implies a potential upside of 30.4% from current levels.

AHCO Stock Analysis: Buy, Sell, or Hold?

AHCO - AdaptHealth Corp. Common Stock

SERVICES-HOME HEALTH CARE SERVICES

$10.74

-0.07 (-0.65%) ▼

5d: -8.44%

30d: -15.1%

90d: +6.44%

HOLD

LOW Confidence

Protect Your AHCO Gains

Analysis Updated: May 14, 2026 12:00 AM ET

Earnings: May 12, 2026 0d

Smart Money Accumulation

AHCO is down 13.3% this week, but smart money is accumulating calls. Top strike: $10 2026-06-18 with 6,750 OI. Call ratio: 100% View Scanner →

Strength: 10.0/10

Get Alerted When AHCO Hits Your Target Price

Join 10,000+ traders who never miss a move

You're in! Check your email to confirm and set your target price.

100% Free No spam, ever Unsubscribe anytime

Interactive Price Chart (1 Month)

Loading historical data...

💡

Bottom Line:
📊 HOLD: AHCO shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.

See Forward Earnings Fair Value & Price Prediction →

Long-Term Wealth Forecast (2031)

Based on Analyst Consensus Growth & Historical Valuation

Adjust Growth Assumption: 25.0%

0% (Stagnation) 50% (Hyper Growth)

EST. PRICE IN 2031

$22.84

Based on 14.5% avg growth

INTRINSIC VALUE TODAY

$14.18

24.3% Margin of Safety

How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 9.7x Exit PE.

View Full DCF Model

In-depth Analysis How we analyze

Valuation Analysis: AHCO is currently trading at $10.74, which is considered oversold relative to its 30-day fair value range of $11.65 to $12.99. The stock's valuation (Forward PE: 8.9) is in line with its historical norms (9.7). Remarkably, the market is currently pricing in an annual earnings decline of 2.8% over the next few years. This pessimistic expectation contrasts with the company's recent 6.7% earnings growth, suggesting potential undervaluation if the company simply maintains stability.

Technical Outlook: Technically, AHCO is in a strong uptrend. The price is currently testing key support at $10.66. A bounce from this level would confirm strength, while a break below could signal further downside.

Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $14.00 (+30.4%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.

Quick Decision Summary

Current Position OVERSOLD

Historical Trading Range $11.65 - $12.99

Company Quality Score 61/100 (BUY)

Volume Confirmation HIGH

Confidence Score 79.5%

Protect Your Profits

Holding AHCO? Use our AI-powered strategies to protect your downside while keeping your long-term position.

View Profit Protection Plan

All Signals

BULLISH: Price oversold vs 30-day range
NEUTRAL: Mixed technical signals (40/100)
BULLISH: High volume confirmation
BULLISH: Trading 30.4% below Wall St target ($14.00)
CAUTION: Recommendation downgraded due to -8.4% 5-day decline

Trading Range Analysis

30-Day Trading Range $11.65 - $12.99

Current vs Trading Range OVERSOLD

Support & Resistance Levels

Support Level $10.66

Resistance Level $13.43

Current Trend Strong Uptrend

Technical data as of May 14, 2026

Fundamental Context

Forward P/E (Next Year Est.) 8.88

Wall Street Target $14.00 (+30.4%)

Revenue Growth (YoY) 5.4%

Earnings Growth (YoY) 6.7%

Profit Margin -2.4%

Valuation Discount vs History -2.8% cheaper

PE vs Historical 8.9 vs 9.7 FAIR

Market-Implied Price Targets If current PE multiple persists

Implied Growth (YoY): -2.8% (market-implied from PE analysis)

1-Year Target $10.44 (-3%)

2-Year Target $10.15 (-6%)

3-Year Target $9.86 (-8%)

3-Yr Target (if PE normalizes) (PE: 9→10) $10.77 (+0%)

3-Year Scenarios Using analyst projected EPS growth

Bull: (PE: 22.0, Growth: 36.8%) $68.19 (+535%)

Base: (SPY PE: 8.9, Growth: 36.8%) $27.48 (+156%)

Bear: (PE: 7.5, Growth: 36.8%) $23.36 (+118%)

💡 Upside Surprise Potential

If earnings stabilize (0% growth), PE could expand from 8.9 to 9.7

Stabilization Target: $11.73 (+9.2%)

PE Expansion Potential: +9.2%

Share & Embed Analysis

Found this analysis useful? Share it with your community or embed the live chart on your blog.

Tweet Reddit

bloggers & journalists: you are free to use our charts with attribution.

Last updated: May 15, 2026 8:07 AM ET
Data refreshes hourly during market hours. Next update: 9:07 AM

🔥 Top Stocks Breaking Out Now

Ticker	Score	Recommendation	Change %

See Full Scanner Results »

Technical Signals Check

Is AHCO showing a specific setup today?

RSI Divergence Check TTM Squeeze Check MACD Crossover Check Gamma Walls Check Unusual Activity Check

Insider Activity (6 Months)

Buys

Sells

Net

INSIDERS BUYING

Recent Transactions

Richard M Cashin Jr BUY 447100 shares 2026-03-20

Richard M Cashin Jr BUY 727 shares 2026-03-19

Richard M Cashin Jr BUY 689336 shares 2026-03-12

View Insider Activity Scanner

Unlock Insider Activity

See real-time buying/selling by company executives for AHCO.

Create Free Account

Already have an account? Log In

Featured in Portfolios

AHCO is a key holding in these high-performance investment strategies.

Rocket Ships Score Based • -2.7% Return

Healthcare Recovery Score Based • -17.1% Return

Healthcare Improvers Score Based • +62.5% Return

MedTech Improvers Score Based • -11.2% Return

Steady Improvers Score Based • -16.4% Return

Tech + Healthcare Improvers Score Based • -16.4% Return

View All Strategies

Top Rated Medical Devices Stocks

Top-rated stocks in Medical Devices by analyst ratings.

Stock	Analyst Consensus	Analyst Target	Tradestie Score
BSX Boston Scientific Corp	STRONG BUY 34 analysts	$85	55 HOLD
DXCM DexCom Inc	STRONG BUY 26 analysts	$84	60 BUY
MDT Medtronic PLC	BUY 32 analysts	$108	62 BUY
ABT Abbott Laboratories	BUY 28 analysts	$119	53 HOLD
EW Edwards Lifesciences Corp	HOLD 32 analysts	$97	52 HOLD

BSX Boston Scientific…

ABT Abbott Laboratori…

53 HOLD

EW Edwards Lifescien…

52 HOLD

Advanced AHCO Option Strategies

Professional options setups generated by AI based on today's AHCO price and gamma walls.

Iron Condor Bull Call Bear Put Collar

More Analysis for AHCO

AHCO Technical Chart AHCO Price Prediction AHCO Earnings Date AHCO Investment Advisor AHCO Fair Price Analyzer AHCO Options Advisor AHCO Options Chain AHCO Options Analysis AHCO Competitors

Compare AHCO with Peers

AHCO vs OPCH
Which one to buy?

AHCO vs ADUS
Which one to buy?

AHCO vs LPRO
Which one to buy?

AHCO vs RPAY
Which one to buy?

AHCO vs SIBN
Which one to buy?

AHCO vs SIBN
Winner: AHCO

AVNS vs AHCO

Create New Comparison View All Competitors

Tradestie